ASTRAZENECA AB - Sweden 

This institution has been merged with: ASTRAZENECA.

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 4.700.000 226.937 1
2010 0 2.748.319 101.465 1

Networking:

Partners:

Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE7
JANSSEN PHARMACEUTICA NV7
ELI LILLY AND COMPANY LIMITED5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
UNIVERSITAET BERN5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
GOETEBORGS UNIVERSITET4
KAROLINSKA INSTITUTE4
NOVARTIS PHARMA4
PFIZER LIMITED4
SANOFIAVENTIS DEUTSCHLAND4
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
F HOFFMANNLA ROCHE3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
UNIVERSITEIT LEIDEN3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UPPSALA UNIVERSITET3
ABBVIE DEUTSCHLAND GMBH & CO KG2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS LEIDEN2
ALZHEIMER EUROPE2
BAYER AKTIENGESELLSCHAFT2
CERTARA UK LIMITED2
CHALMERS TEKNISKA HOEGSKOLA AB2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ENAMINE LIMITED LIABILITY COMPANYRESEARCH AND PRODUCTION ENTERPRISE2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN SYNCHROTRON RADIATION FACILITY2
GIOTTO BIOTECH2
GLAXOSMITHKLINE BIOLOGICALS2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
KAROLINSKA INSTITUTET2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LEAD DISCOVERY CENTER2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE2
ORION OYJ2
RIJKSUNIVERSITEIT GRONINGEN2
SANOFI PASTEUR2
SP SWEDISH NATIONAL TESTING AND RESEARCH INSTITUTE2
STICHTING VUMC2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAROS CHEMICALS GMBH & CO KG2
TECHNISCHE UNIVERSITAET MUENCHEN2
TECHNISCHE UNIVERSITEIT EINDHOVEN2
THE UNIVERSITY OF SHEFFIELD2
UCB BIOPHARMA SPRL2
UCB PHARMA2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITAET HAMBURG2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAT WIEN2
UNIVERSITE DE BORDEAUX2
UNIVERSITE VICTOR SEGALEN BORDEAUX II2
UNIVERSITEIT ANTWERPEN2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF LEEDS2
UNIWERSYTET JAGIELLONSKI2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
AALTO KORKEAKOULUSAATIO SR1
AARHUS UNIVERSITETSHOSPITAL1
ABBVIE1
ABBVIE1
ABBVIE INC1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACTELION PHARMACEUTICALS1
ALLERGAN LIMITED1
ALMAC DIAGNOSTICS LIMITED1
ALZECURE DISCOVERY1
ALZHEIMER'S RESEARCH UK1
AMGEN LIMITED1
ANANAS NANOTECH1
ANTAROS MEDICAL AB1
ARTTIC1
ASDM CONSULTING1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION POUR LA RECHERCHE ET LE DEVELOPPEMENT DES METHODES ET PROCESSUS INDUSTRIELS1
ASTELLAS PHARMA EUROPE BV1
ASTEX1
AVANTEA1
AXON NEUROSCIENCE SE1

Constancy:

Total number of partners: 477
Partner loyalty:
Frequent Partner: (> 2 projects): 105
Rare Partner: 372
Frequent / Rare Partner Ratio: 0.28

Project overview:

Start dateProjectacronymrolefundingpartners
2011-01-01Stem Cells for Relevant Efficient Extended and Normalized Toxicology SCR&TOXparticipant4.700.00015
2010-01-01Arrhythmogenic potential of drugs ARITMOparticipant2.748.31920